Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

709.39
-22.8418-3.12%
Number of Gainers:- -
Number of Losers:4
Number of Flat:- -
PE:- -
High:735.36
Open:723.48
Low:706.95
Close:732.23
Volume:53.61M
Turnover:963.36M
Market Cap:22.68B
Float Cap:17.47B

Loading ...

OverviewNews

Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026

THOMSON REUTERS
·
Oct 01

Tempus AI Diagnostics CEO Thomas Edward Schoenherr Disposes of $873,885 in Common Shares

Reuters
·
Sep 30

Tempus AI Wins FDA Clearance for ECG-MR Tool to Flag Undiagnosed Mitral Regurgitation

Reuters
·
Sep 28

Tempus Receives FDA Clearance for Its Ecg-Mr AI Product Designed to Identify Undiagnosed Mitral Regurgitation

THOMSON REUTERS
·
Sep 28

ToolGen Raises KRW 19.5 Billion to Fund CRISPR Patent Battles and R&D

TIPRANKS
·
Sep 28

Snowflake, Palo Alto, Dell, GameStop, Crispr Insider Shock

TIPRANKS
·
Sep 26

Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6

Reuters
·
Sep 25

Tempus AI CEO and Chairman Eric P. Lefkofsky Disposes of $17,868,777.62 in Class a Shares

Reuters
·
Sep 25

Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know

TradingKey
·
Sep 25

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Sep 25

Editas slips amid pressure on gene-editing sector after Anthropic update

TIPRANKS
·
Sep 24

Claude discovers novel enzyme system with CRISPR-like repeats

TIPRANKS
·
Sep 24

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.